HYBRID Anesthesiology Research Seminar: Nurulain Zaveria (Astraea Therapeutics, LLC) – “Advancing the development of Nociceptin Opioid Receptor-targeted ligands as therapeutics for Substance use disorders”

September 27, 2022
4:00 pm - 5:00 pm
,
Zoom/Eric P. Newman Education Center, Seminar Room A (EPNEC; Medical Campus)
Add to: Google Calendar | Outlook | iCal File

“Advancing the development of Nociceptin Opioid Receptor-targeted ligands as therapeutics for Substance use disorders”

Hosted by the Department of Anesthesiology

For inquiries contact Amber Spies.